| GEICO: Antonio González, Clínica Universidad de Navarra, Madrid, Spain ESMO: Andrés Cervantes, University Hospital, INCLIVA, Valencia, Spain |
| Chairs: Ignacio Romero, Fundación Instituto Valenciano de Oncología, Valencia, Spain Andrés Poveda, Initia Oncology, Hospital Quironsalud, Valencia, Spain |
|
| 08:45 - 09:25 | Biomarkers in Ovarian Cancer: To be or not to be Michael Birrer, O'Neal Comprehensive Cancer Center at UAB (AL), USA |
| Chairs: Michael Birrer O'Neal Comprehensive Cancer Center at UAB (AL), USA Jose A López-Guerrero Fundación Instituto Valenciano de Oncología, Valencia, Spain |
|
| 09:25 - 09:45 | Precision Medicine in epithelial ovarian cancer Iain McNeish Imperial College London, UK |
| 09:45 - 10:05 | The potential role of liquid biopsies in ovarian cancer Martin Widschwendter University College London Hospital, London, UK |
| 10:05 - 10:25 | TILs and PD-L1 expression in ovarian cancer: What to do with it? George Coukos University of Lausanne, Switzerland |
| 10:25 - 10:45 | Discussion All |
| Chairs: Jonathan A. Ledermann University College London Cancer Institute, London, UK Luis Chiva Clínica Universidad de Navarra, Madrid, Spain |
||
| 11:15 - 11:35 | How to manage lymph nodes in ovarian cancer in 2019 Philipp Harter Kliniken Essen-Mitte, Essen, Germany |
|
| 11:35 - 11:55 | Can we predict who lives long with ovarian cancer? Michael A. Bookman Kaiser Permanente, Northern California, (CA), USA |
|
| 11:55 - 12:15 | Landscape of systemic therapy for ovarian cancer in 2019 Keiichi Fujiwara Saitama Medical University International Medical Center, Saitama, Japan |
|
| 12:15 - 12:35 | Discussion All |
|
| 12:35 - 13:35 | Does HIPEC improve survival in AOC? |
|
| Chair: Jan B. Vermorken Antwerp University Hospital, Edegem, Belgium Giovanni Scambia Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy |
||
| PRO: Gabe Sonke Netherlands Cancer Institute, Amsterdam, Netherland CONS: Ignace Vergote University Hospital Leuven, Belgium |
||
| 13:15 - 13:35 | Discussion All |
|
| Chairs: Eric Pujade-Lauraine Hôpital Hotel-Dieu, Paris, France Ana Oaknin Vall d’Hebron Institute of Oncology, Barcelona, Spain |
|
| 15:00 - 15:20 | Who needs surgery? Jalid Sehouli Charité University of Medicine, Berlin, Germany |
| 15:20 - 15:40 | Do all patients need systemic therapy? Michael Friedlander Royal Hospital for Women and Nelune Cancer Center, Sydney, Australia |
| 15:40 - 16:10 | Landscape of systemic therapy for recurrent ovarian cancer in 2019 Sandro Pignata National Cancer Institute, Naples, Italy |
| 16:10 - 16:30 | Discussion All |
| Chairs: Mansoor Mirza Copenhagen University Hospital, Copenhagen, Denmark Andres Redondo Hospital Universitario La Paz, Madrid, Spain |
|
| 17:00 - 17:20 | Immunotherapy in Ovarian Cancer: Still promising? Antonio González Clínica Universidad de Navarra, Madrid, Spain |
| 17:20 - 17:40 | New Strategies in Ovarian Cancer Treatment Elise C. Kohn National Cancer Institute, Bethesda (MD), USA |
| Andrés Poveda Initia Oncology, Hospital Quironsalud, Valencia, Spain |